title: "Tolerogenic effect" of the liver for a small bowel allograft.
abstract: A newly developed liver/small bowel transplantation model (LSBTx) was used to investigate the tolerogenic effect of a liver allograft toward a simultaneously transplanted small bowel. Small bowel transplantation (SBTx) under high-dose immunosuppression was compared to LSBTx with a lower FK506 dosage. Syngeneic Lewis [(LEW) to LEW] and two fully allogeneic rat strain combinations (Brown Norway-to-LEW and Dark Agouti-to-LEW) were used. Clinical course and histological findings after SBTx demonstrated a chronic rejection of the small bowel allograft within 100 days. However, after LSBTx long-term acceptance (> 150 days) was achieved after a transient rejection crisis, although initial immunosuppression was significantly lower. Furthermore, indicator heart transplantations demonstrated the induction of donor-specific tolerance in both allogeneic strain combinations. In contrast to other LSBTx rat models, these results reflect observations after human LSBTx, in which the rate of acute and chronic rejection is also significantly lower than after human SBTx.
authors: Department of Surgery, University of Wuerzburg, Germany. 093154535-0001@t-online.de
authors: D
authors: D
authors: Meyer
authors: C
authors: C
authors: Otto
authors: C
authors: C
authors: Rummel
authors: H J
authors: HJ
authors: Gassel
authors: W
authors: W
authors: Timmermann
authors: K
authors: K
authors: Ulrichs
authors: A
authors: A
authors: Thiede
mesh_terms: D000208:Acute Disease; D000818:Animals; D002908:Chronic Disease; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007421:Intestine, Small / Q000637:transplantation*; D016031:Liver Transplantation / Q000276:immunology* / Q000379:methods*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016559:Tacrolimus / Q000627:therapeutic use; D014184:Transplantation, Homologous / Q000276:immunology* / Q000379:methods*; D014185:Transplantation, Isogeneic / Q000276:immunology / Q000379:methods
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus